Market Overview

12 Biggest Mid-Day Losers For Monday

  • Microbot Medical Inc (NASDAQ: MBOT) shares dropped 28.9 percent to $2.71. Microbot Medical reported a $10 million registered direct offering
  • ChinaCache International Holdings Ltd (NASDAQ: CCIH) shares dipped 17.6 percent to $1.39.
  • NewLink Genetics Corp (NASDAQ: NLNK) fell 12 percent to $11.03 in pre-market trading after the company reported that indoximod + PROVENGE resulted in statistically significant improvement in rPFS for patients with mCRPC in Phase 2 trial.
  • Juno Therapeutics Inc (NASDAQ: JUNO) shares tumbled 8.6 percent to $23.95. Juno Therapeutics presented updated data from the TRANSCEND trial of JCAR017 at the ASCO Annual Meeting.
  • Spi Energy Co Ltd (ADR) (NASDAQ: SPI) shares fell 8 percent to $1.39.
  • Endocyte, Inc. (NASDAQ: ECYT) shares declined 7.3 percent to $1.77. Cowen & Co. downgraded Endocyte from Outperform to Market Perform, while Wedbush downgraded the stock from Outperform to Neutral.
  • Herbalife Ltd. (NYSE: HLF) shares slipped 6.3 percent to $69.24 after the company cut its sales forecast for the current quarter. Herbalife expects Q2 revenue to decline by 6 percent to 2 percent, and adjusted earnings of $0.95 to $1.15 per share.
  • Insys Therapeutics Inc (NASDAQ: INSY) shares dropped 6.1 percent to $13.23 as the company issued a statement on negative media reports.
  • Perrigo Company plc (NYSE: PRGO) declined 5.7 percent to $69.29. RBC Capital downgraded Perrigo from Sector Perform to Underperform.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) shares dropped 3.5 percent to $18.12 after the company reported weaker-than-expected earnings for its first quarter.
  • CGG SA (ADR) (NYSE: CGG) shares fell 3.2 percent to $6.61 after climbing 25.78 percent on Friday.
  • Keane Group Inc (NYSE: FRAC) declined 3 percent to $15.12. Susquehanna initiated coverage on Keane Group with a Neutral rating.

Posted-In: Mid-Day LosersNews Movers & Shakers Intraday Update Markets


Related Articles (CCIH + CGG)

View Comments and Join the Discussion!

A Soaring Actively Managed Fund

12 Biggest Mid-Day Gainers For Monday